Onchocerciasis Treatment Global Market Report 2025

Description

Onchocerciasis treatment encompasses medical and therapeutic interventions aimed at managing and eliminating infections caused by Onchocerca volvulus, the parasite responsible for river blindness-a disease that primarily impacts the skin and eyes. The key objective of treatment is to eradicate the microfilariae (immature larvae) to reduce transmission, alleviate symptoms, and lower the risk of vision impairment.

The primary drugs used in onchocerciasis treatment include ivermectin, doxycycline, albendazole, and moxidectin. Ivermectin is an antiparasitic agent employed in treating several parasitic diseases, including onchocerciasis (river blindness), by targeting and killing the parasite's larvae (microfilariae). Treatment approaches consist of mass drug administration (MDA) and targeted therapies, utilizing various forms of administration such as oral, injectable, and topical options. These treatments are distributed through hospital pharmacies, retail pharmacies, and online platforms, and they cater to end-users including hospitals and clinics, home-based care settings, and government as well as non-governmental initiatives.

The onchocerciasis treatment market research report is one of a series of new reports from The Business Research Company that provides onchocerciasis treatment market statistics, including the onchocerciasis treatment industry global market size, regional shares, competitors with the onchocerciasis treatment market share, detailed onchocerciasis treatment market segments, market trends, opportunities, and any further data you may need to thrive in the onchocerciasis treatment industry. This onchocerciasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The onchocerciasis treatment market size has grown strongly in recent years. It will grow from $1.03 billion in 2024 to $1.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period is due to an increase in patients suffering from eye-associated issues, an increase in parasitic infections, an increase in the number of targeted treatment centers, a rise in education campaigns, and an increase in the geriatric population.

The onchocerciasis treatment market size is expected to see strong growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period is due to factors such as rising prevalence in endemic regions, rising demand for surgical procedures, expanding healthcare infrastructure, growing prevalence of chronic diseases, and increasing healthcare investments. Major trends in the forecast period include a shift towards single-dose regimens, advancements in macrocyclic lactone formulations, the emergence of Wolbachia-targeting therapies, the integration of artificial intelligence (AI) in drug discovery, and the development of pediatric-specific treatments.

The increasing number of individuals suffering from eye-related conditions is expected to drive the growth of the onchocerciasis treatment market. These conditions encompass a range of vision and ocular health issues, including infections, injuries, and chronic diseases such as glaucoma and cataracts. A key contributor to this rise is the extended screen time and prolonged exposure to digital devices. Onchocerciasis treatment plays a crucial role in preventing and managing vision loss by eliminating the parasitic infection responsible for inflammation and ocular damage. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that approximately 20.5 million Americans over the age of 40 have cataracts in at least one eye, representing 17.2% of that age group. The number is expected to reach nearly 30 million by 2028. Consequently, the growing prevalence of eye-related issues is boosting the demand for onchocerciasis treatment.

The increasing need for surgical procedures is also contributing to the growth of the onchocerciasis treatment market. Surgical procedures involve medical interventions to remove or repair tissues affected by disease and are often required when drug treatments fail or complications pose long-term health risks. The progression of onchocerciasis to advanced stages in some patients necessitates surgical intervention to prevent permanent damage such as vision loss or disfigurement. In response, healthcare systems are enhancing their surgical capabilities and adopting advanced techniques, thereby supporting market expansion. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS) reported that nearly 35 million aesthetic procedures were performed globally in 2023, marking a 3.4% increase from the previous year. Surgical procedures rose by 5.5%, with more than 15.8 million performed by plastic surgeons. This growing demand for surgeries is reinforcing the onchocerciasis treatment market.

Leading companies in the onchocerciasis treatment market are prioritizing the development of innovative antiparasitic drugs to enhance treatment outcomes and accessibility. These drugs target parasites such as worms and protozoa, which are responsible for infections like onchocerciasis. In December 2024, Medicines Development for Global Health (MDGH), an Australian non-profit biopharmaceutical company, received approval from the Ghana Food and Drugs Authority for Moxidectin 2 mg oral tablets, intended for the treatment of river blindness in individuals aged four and above. This approval paves the way for community-wide mass drug administration initiatives in Ghana, utilizing moxidectin's superior efficacy and extended duration of action compared to ivermectin. Through this initiative, MDGH aims to increase access to a more effective treatment, supporting widespread implementation in endemic areas.

Major players in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos - Fundacao Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, and Cerata Pharmaceuticals Inc.

North America was the largest region in the onchocerciasis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in onchocerciasis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the onchocerciasis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The onchocerciasis treatment market consists of revenues earned by entities providing services such as mass drug administration (MDA) campaigns, community-based health outreach, disease surveillance and diagnostics, vector control initiatives, and public health education. The market value includes the value of related goods sold by the service provider or included within the service offering. The onchocerciasis treatment market also includes sales of antiparasitic drugs, diagnostic kits, drug delivery tools, and protective supplies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Onchocerciasis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on onchocerciasis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for onchocerciasis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The onchocerciasis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Ivermectin; Doxycycline; Albendazole; Moxidectin
2) By Treatment Strategy: Mass Drug Administration (MDA); Targeted Treatment
3) By Mode Of Administration: Oral; Injectables; Topical
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospitals And Clinics; Home Care Settings; Government And Non-Governmental Programs
Subsegments:
1) By Ivermectin: Oral Tablets; Community-Based Mass Drug Administration (MDA) Kits; Fixed-Dose Combination Therapies; Pediatric Formulations
2) By Doxycycline: Oral Capsules; Extended-Release Tablets; Combination With Anti-Wolbachia Therapy; Hospital-Based Prescription Treatments
3) By Albendazole: Single-Dose Oral Tablets; Combination Therapy With Ivermectin; Government-Supplied Preventive Chemotherapy Packages; Over-The-Counter (OTC) Formulations In Endemic Areas
4) By Moxidectin: Oral Tablets; Long-Acting Formulations; Adult-Only Dosing Regimens; Clinical Trial-Based Access Programs
Companies Mentioned: Merck & Co. Inc.; Teva Pharmaceutical Industries Limited; Hetero Labs Limited; Sun Pharmaceutical Industries Limited; Intas Pharmaceuticals Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r36002

1. Executive Summary

2. Onchocerciasis Treatment Market Characteristics

3. Onchocerciasis Treatment Market Trends And Strategies

4. Onchocerciasis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Onchocerciasis Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Onchocerciasis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Onchocerciasis Treatment Market Growth Rate Analysis
5.4. Global Onchocerciasis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Onchocerciasis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Onchocerciasis Treatment Total Addressable Market (TAM)

6. Onchocerciasis Treatment Market Segmentation

6.1. Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ivermectin
Doxycycline
Albendazole
Moxidectin
6.2. Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mass Drug Administration (MDA)
Targeted Treatment
6.3. Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectables
Topical
6.4. Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Home Care Settings
Government And Non-Governmental Programs
6.6. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Community-Based Mass Drug Administration (MDA) Kits
Fixed-Dose Combination Therapies
Pediatric Formulations
6.7. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Capsules
Extended-Release Tablets
Combination With Anti-Wolbachia Therapy
Hospital-Based Prescription Treatments
6.8. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Dose Oral Tablets
Combination Therapy With Ivermectin
Government-Supplied Preventive Chemotherapy Packages
Over-The-Counter (OTC) Formulations In Endemic Areas
6.9. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Moxidectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Long-Acting Formulations
Adult-Only Dosing Regimens
Clinical Trial-Based Access Programs

7. Onchocerciasis Treatment Market Regional And Country Analysis

7.1. Global Onchocerciasis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Onchocerciasis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Onchocerciasis Treatment Market

8.1. Asia-Pacific Onchocerciasis Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Onchocerciasis Treatment Market

9.1. China Onchocerciasis Treatment Market Overview
9.2. China Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Onchocerciasis Treatment Market

10.1. India Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Onchocerciasis Treatment Market

11.1. Japan Onchocerciasis Treatment Market Overview
11.2. Japan Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Onchocerciasis Treatment Market

12.1. Australia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Onchocerciasis Treatment Market

13.1. Indonesia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Onchocerciasis Treatment Market

14.1. South Korea Onchocerciasis Treatment Market Overview
14.2. South Korea Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Onchocerciasis Treatment Market

15.1. Western Europe Onchocerciasis Treatment Market Overview
15.2. Western Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Onchocerciasis Treatment Market

16.1. UK Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Onchocerciasis Treatment Market

17.1. Germany Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Onchocerciasis Treatment Market

18.1. France Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Onchocerciasis Treatment Market

19.1. Italy Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Onchocerciasis Treatment Market

20.1. Spain Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Onchocerciasis Treatment Market

21.1. Eastern Europe Onchocerciasis Treatment Market Overview
21.2. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Onchocerciasis Treatment Market

22.1. Russia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Onchocerciasis Treatment Market

23.1. North America Onchocerciasis Treatment Market Overview
23.2. North America Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Onchocerciasis Treatment Market

24.1. USA Onchocerciasis Treatment Market Overview
24.2. USA Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Onchocerciasis Treatment Market

25.1. Canada Onchocerciasis Treatment Market Overview
25.2. Canada Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Onchocerciasis Treatment Market

26.1. South America Onchocerciasis Treatment Market Overview
26.2. South America Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Onchocerciasis Treatment Market

27.1. Brazil Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Onchocerciasis Treatment Market

28.1. Middle East Onchocerciasis Treatment Market Overview
28.2. Middle East Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Onchocerciasis Treatment Market

29.1. Africa Onchocerciasis Treatment Market Overview
29.2. Africa Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Onchocerciasis Treatment Market Competitive Landscape And Company Profiles

30.1. Onchocerciasis Treatment Market Competitive Landscape
30.2. Onchocerciasis Treatment Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Hetero Labs Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

31. Onchocerciasis Treatment Market Other Major And Innovative Companies

31.1. Dr. Reddy's Laboratories Inc.
31.2. Cipla Limited
31.3. Endo Inc.
31.4. Lupin Limited
31.5. Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos - Fundacao Oswaldo Cruz (Fiocruz)
31.6. AMGIS Lifescience Ltd.
31.7. Drugs for Neglected Diseases initiative (DNDi)
31.8. Rakshit Drugs Pvt. Ltd.
31.9. Hangzhou Longshine Bio-Tech Co. Ltd.
31.10. OREX Pharma Private Limited
31.11. Angle Bio Pharma Pvt. Ltd.
31.12. Senores Pharmaceuticals Inc.
31.13. Avenacy LLC
31.14. Dolphin Pharma
31.15. Cerata Pharmaceuticals Inc.

32. Global Onchocerciasis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Onchocerciasis Treatment Market

34. Recent Developments In The Onchocerciasis Treatment Market

35. Onchocerciasis Treatment Market High Potential Countries, Segments and Strategies

35.1 Onchocerciasis Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Onchocerciasis Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Onchocerciasis Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer